Topic Listing for PRA International

Accounts Receivable Unbilled Services Accrued Expenses
Acquisitions Adjustment
Advance Billings Aggregated Option Sar Exercises 2005 Fy-end Values
Allocation Among Compensation Components Allowance Doubtful Accounts
Amendment Announced Restructuring
Annual Performance-based Cash Compensation Annual Report Pursuant Securities Exchange Act 1934
Audit Committee Report Authorized Shares
Backlog Base Compensation
Because Most Clinical Development Service Revenue Long-term Fixed-fee Because Typically Not Paid Dividends Anticipate Paying Common
Beneficial Ownership Reporting Compliance Board Directors Compensation
Board Organization Meetings Bruce Teplitzky Executive Vice President Business Development
Business Adjournments Business Businesses Customers Subject Extensive Regulation Results Operations
Business Depends Senior Management Team Loss Member Harm Business Harmed Cannot Successfully Integrate Future Acquisitions
Business Harmed Companies Pharmaceutical Biotechnology Industries Offer Services Business Harmed Unable Manage Growth Effectively
Capital Leases Cash Equivalents
Cautionary Regarding Forward-looking Statements Certain Anti-takeover Effects
Certain Relationships Related Transactions Change Control
Changes Internal Control Over Financial Reporting Circumstances Beyond Control Cause Cro Industry Suffer Reputational
Clinical Pharmacology Center Phase Clinical Research Services Create Risk Liability Required Pay
Clinical Trials Management Services Committee Meetings Deliberations
Committees Conclusion Common Stock Warrants
Compared 2003 Compared 2004
Compared 2005 Compensation Benchmarking Peer Group
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Consultants Compensation Objectives
Compete Highly Competitive Market Not Successfully Business Harmed Competition
Competitive Strengths Composition
Comprehensive Income Loss Concentration Credit Risk
Consolidated Financial Statements Statement Schedule Consolidated Financial Statements Statement Schedules
Contracts Generally Terminable Little Notice Termination Large Contract Contractual Obligations Commercial Commitments
Credit Agreement Critical Accounting Policies Estimates
Cro Industry Trends Customers Suppliers
David Dockhorn Phd Executive Vice President Global Clinical Debt Issuance Costs
Depend Limited Number Clients Loss Significant Decrease Business Depreciation Amortization
Derivatives Determination Compensation Awards
Direct Costs Director Compensation
Distribution Date Exercisability Dividend Policy
Drug Development Cycle Early Development Services
Effectiveness Disclosure Controls Procedures Employee Benefit Plan
Employee Health Insurance Employee Stock Purchase Plan
Employees Employment Agreements
Environmental Regulation Liability Estimates
Evaluation Disclosure Controls Procedures Exact Name Registrant Specified Charter
Exchange Exchange Rate Fluctuations
Executive Compensation Executive Officers
Experience Difficulties Delays Unexpected Costs Completing Achieving Anticipated Exposure Exchange Rate Fluctuations Negatively Impact Results Operations
Fair Value Financial Instruments Fees Paid Independent Auditors
Find Information Fixed Assets
Flip-in Flip-over
Foreign Currency Hedges Foreign Currency Translation
Foreign Exchange Risk Form 10-q
Further Information Gail Omullan Senior Vice President Talent Management
Global Drug Approval Process Global Scientific Medical Affairs
Goodwill Indefinite-lived Intangible Assets Goodwill Other Intangibles
Government Regulation Gross-up Payments Non-competition Restrictions
Health Care Industry Reform Reduce Eliminate Business Opportunities Held 2007
Impairment Long-lived Assets Implemented Certain Provisions Make Change Board Directors Control
Income Taxes Incur Liability Hazardous Material Contamination Business Harmed
Index Index Consolidated Financial Statements
Inflation Initial Public Offering
Insurance Intellectual Property
Interest Rate Risk Internal Control Over Financial Reporting
Internal Pay Equity James Powers Executive Vice President Business Development Secretary
Largest Stockholders Continue Significant Influence Over They Make Lease Termination
Leased Facilities Dockhorn Properties Llc Legal Proceedings
Liability Insurance Liquidity Capital Resources
Long-lived Assets Long-term Performance-based Equity Incentive Program
Management Stock Purchase Plan Managements Annual Report Internal Control Over Financial Reporting
Managements Report Internal Control Over Financial Reporting Matthew Bond Executive Vice President Chief Financial Officer
Meetings Procedures Members Audit Committee
Monika Pietrek Phd Executive Vice President Global Scientific Monika Pietrek Phd Executive Vice President Scientific Medical
Nature Operations Net Income Per Share
Nomination Directors Non-gaap Financial Measures
Off-balance Sheet Arrangements Operating Leases
Option Exercises Stock Vested Other Elements Compensation
Overview Part
Part Other Information Performance Graph
Performance-based Compensation Pharma Emarket Llc
Pharma Market Llc Policy Regarding 162
Post-termination Payments Potential Liability Insurance
Potential Payments Termination Change Control Pra International
Pra International Adopts Stockholder Rights Plan Pra International Subsidiaries Notes Consolidated Condensed Financial Statements
Preferred Stock Price Common Stock Fluctuate Significantly Lose Part Investment
Principles Consolidation Produced 2006 Including Data 2005
Product Registration Services Project Assurance
Proposals Stockholders 2008 Provide Services Emerging Companies Unable Pay
Proxy Solicitation Proxy Statement
Purpose Quarterly Operating Results Vary Negatively Affect Market Price
Quorum Vote Required Ratification Auditors
Recent Accounting Pronouncements Recent Developments
Recent Sales Unregistered Securities Record Date Outstanding Shares Entitled Vote
Redemption Registrants Telephone Number Including Area Code
Registration Rights Agreement Reimbursement Revenue Reimbursable Out-of-pocket Costs
Related-party Transactions Report Independent Registered Public Accounting Firm
Revenue Recognition Review Ceo Compensation Components
Revision Rights Holders
Risk Factors Risks Other Factors
Risks Related Common Stock Risks Related Industry
Role Executive Officers Compensation Process Sale Substantial Number Shares Common Stock Public Market
Sales Marketing Schedule
Secondary Offering Securities Authorized Issuance Equity Compensation Plans
Securities Exchange Act 1934 Segment Reporting Operations Geographic Area
Selling General Administrative Expenses Senior Management Team Important Business Loss Member Harm
Service Revenue Services Subject Evolving Industry Standards Rapid Technological Changes
Severance Signatures
Significant Amount Goodwill Balance Sheet Downturn Business Industry Significant Customers
Special Regarding Forward-looking Statements Special Regarding Risks Forward-looking Statements
Stock Option Grants Stock Option Repurchase Dividend Bonus Payment
Stock Options Stock-based Compensation
Stockholders Agreement Stockholders Agreements
Stockholders Equity Strategy
Subject Certain Risks Associated Foreign Operations Subsequent Event
Summary Compensation Supplemental Cash Flow Information
Table Contents Tax Valuation Allowance
Termination Connection Change Control Termination Without Change Control
Unable Recruit Retain Qualified Personnel Not Able Expand Unable Restore Organic Growth Phase Service Areas Not
Unbilled Services Variation Quarterly Operating Results
Voting Proxies Revocation William Bucky Walsh Executive Vice President Corporate Development
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki